Assisted reproductive drug development puts forward strict requirements on
follicle‑stimulating hormone raw material, pushing pharmaceutical buyers to
search for a stable Urofollitropin supplier. Urofollitropin, urinary‑derived
follicle‑stimulating hormone (FSH), is widely used to support ovarian follicle
growth in infertility treatment formulations. Product performance directly
determines safety and effectiveness of downstream finished injectable drugs.
Many purchasers encounter practical challenges: fluctuating FSH biological
potency, residual impurity proteins, insufficient stability data and inflexible
delivery schedules. A reliable Urofollitropin supplier should integrate
independent production capacity, complete quality control and
international‑oriented document support. Kangyuan from Qingdao focuses on
urinary‑extracted gonadotropin APIs. Our production workflow applies advanced
chromatography separation and membrane purification technology to remove
miscellaneous protein components.
As a responsible Urofollitropin supplier, Kangyuan conducts strict
biological potency assay, endotoxin detection, related‑substance inspection and
virus safety validation for each batch. We offer sample supply for feasibility
study, and scalable bulk supply for commercial production. Full sets of
technical files including COA, stability reports can be provided to assist
overseas customers for registration submission.
Our technical team can share advice about recommended storage temperature,
handling precautions and formulation compatibility. For pharma companies looking
for qualified urinary FSH raw material, feel free to send inquiries to Kangyuan
for further cooperation possibilities.